$15.4M accounts payable - $7.5M $19.1M convertib
Post# of 30029
(Total Views: 457)
Posted On: 04/16/2022 2:14:16 AM
.jpg)
$15.4M accounts payable - $7.5M
$19.1M convertibles - (between $13.8M and $17.7M)
No revenue in 2021 but hempori worth $30k more
Still have 28M shares of Todos
25% of any excess waterfall
Let's assume no excess waterfall, minimum convertible extinguish, no Todos appreciation. That means our accounts payable is cut in half to $7.9M and convertibles will total $5.3M in convertible debt. And all we lose is cutanogen. Let's see what happens with this Emerald Organic stake. Also probably nothing to get out of that, but...
MANF and ELTO are the big tickets and they're so much easier to fund when whoever gets involved isn't competing with all this legacy BS. Clear the books!
$19.1M convertibles - (between $13.8M and $17.7M)
No revenue in 2021 but hempori worth $30k more
Still have 28M shares of Todos
25% of any excess waterfall
Let's assume no excess waterfall, minimum convertible extinguish, no Todos appreciation. That means our accounts payable is cut in half to $7.9M and convertibles will total $5.3M in convertible debt. And all we lose is cutanogen. Let's see what happens with this Emerald Organic stake. Also probably nothing to get out of that, but...
MANF and ELTO are the big tickets and they're so much easier to fund when whoever gets involved isn't competing with all this legacy BS. Clear the books!
(1)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼